Nan Chiang

Active 1998–2025

71
Papers
23,444
Citations
66
h-index
70
i10-index

Citations

Citations per year for Nan Chiang1992: 5 citations1996: 1 citations1999: 3 citations2000: 15 citations2001: 35 citations2002: 38 citations2003: 53 citations2004: 101 citations2005: 127 citations2006: 137 citations2007: 163 citations2008: 200 citations2009: 224 citations2010: 370 citations2011: 337 citations2012: 367 citations2013: 413 citations2014: 315 citations2015: 377 citations2016: 353 citations2017: 414 citations2018: 381 citations2019: 985 citations2020: 1,134 citations2021: 1,048 citations2022: 969 citations2023: 658 citations2024: 860 citations2025: 358 citations2026: 10 citations1993–1995: no citations, so these years are not shown1997–1998: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,021 citing papers, 27.5% of this breakdownChina: 690 citing papers, 9.4% of this breakdownUnited Kingdom: 602 citing papers, 8.2% of this breakdownGermany: 421 citing papers, 5.7% of this breakdownItaly: 360 citing papers, 4.9% of this breakdownCanada: 297 citing papers, 4% of this breakdownJapan: 237 citing papers, 3.2% of this breakdownFrance: 227 citing papers, 3.1% of this breakdownSpain: 215 citing papers, 2.9% of this breakdownBrazil: 188 citing papers, 2.6% of this breakdownAustralia: 181 citing papers, 2.5% of this breakdownSweden: 156 citing papers, 2.1% of this breakdown
0%27.5%Other 23.9%

Fields

  • Medicine31.9%
  • Biochemistry, Genetics and Molecular Biology23.7%
  • Nursing21.6%
  • Immunology and Microbiology11.2%
  • Neuroscience4.9%
  • Dentistry2.9%
  • Other3.8%

Topics

  • Fatty Acid Research and Health10.3%
  • Eicosanoids and Hypertension Pharmacology5.6%
  • Immune Response and Inflammation4.1%
  • Immune cells in cancer2.3%
  • Inflammatory mediators and NSAID effects1.9%
  • Cholesterol and Lipid Metabolism1.8%
  • Other74%

Coauthors

All papers

Open in search
  1. The Concise Guide to PHARMACOLOGY 2023/24: G protein-coupled receptors

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Geoffrey Burnstock, Girolamo Calò, Justo P. Castaño, Kevin Catt, Stefania Ceruti, Paul L. Chazot, Nan Chiang, Bice Chini, Jerold Chun, Antonia Cianciulli, Olivier Civelli, Lucie H. Clapp, Réjean Couture, Helen M. Cox, Zsolt Csaba, Cláes Dahlgren, Gordon Dent, Steven D. Douglas, Pascal Dournaud, Satoru Eguchi, Emanuel Escher, Edward J. Filardo, Tung M. Fong, Marta Fumagalli, Raul R. Gainetdinov, Michael L. Garelja, Marc de Gasparo, Craig Gerard, Marvin C. Gershengorn, Fernand Gobeil, Theodore L. Goodfriend, Cyril Goudet, Lukas Grätz, Karen J. Gregory, Andrew L. Gundlach, Jörg Hamann, Julien Hanson, Richard L. Hauger, Debbie L. Hay, Ákos Heinemann, Deron R. Herr, Morley D. Hollenberg, Nicholas D. Holliday, Mastgugu Horiuchi, Daniël Hoyer, László Hunyady, Ahsan Husain, Adriaan P. IJzerman, Tadashi Inagami, Kenneth A. Jacobson, Robert T. Jensen, Ralf Jockers, Deepa Jonnalagadda, Sadashiva S. Karnik, Klemens Kaupmann, Jacqueline Kemp, Charles Kennedy, Yasuyuki Kihara, Takio Kitazawa, Paweł Kozielewicz, Hans‐Jürgen Kreienkamp, Jyrki P. Kukkonen, Tobias Langenhan, Dan Larhammar, Katie Leach, Davide Lecca, John D. Lee, Susan E. Leeman, Jérôme Leprince, Xaria X. Li and 66 more - British Journal of Pharmacology 2023 cited by 388

  2. Polyunsaturated fatty acids and fatty acid-derived lipid mediators: Recent advances in the understanding of their biosynthesis, structures, and functions

    Authors: , , , , , , , , , , , - Progress in Lipid Research 2022 cited by 615

  3. Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators

    Authors: , , - Nature reviews. Immunology 2008 cited by 2,892

  4. Specialized pro-resolving mediator network: an update on production and actions

    Authors: , - Essays in Biochemistry 2020 cited by 419

  5. Novel Functional Sets of Lipid-Derived Mediators with Antiinflammatory Actions Generated from Omega-3 Fatty Acids via Cyclooxygenase 2–Nonsteroidal Antiinflammatory Drugs and Transcellular Processing

    Authors: , , , , , - The Journal of Experimental Medicine 2000 cited by 1,182

  6. Lipid Mediators in the Resolution of Inflammation

    Authors: , , , - Cold Spring Harbor Perspectives in Biology 2014 cited by 553

  7. Infection regulates pro-resolving mediators that lower antibiotic requirements

    Authors: , , , , , , - Nature 2012 cited by 655

  8. THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: G protein‐coupled receptors

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Kevin Catt, Stefania Ceruti, Paul L. Chazot, Nan Chiang, Bice Chini, Jerold Chun, Antonia Cianciulli, Olivier Civelli, Lucie H. Clapp, Réjean Couture, Zsolt Csaba, Cláes Dahlgren, Gordon Dent, Khuraijam Dhanachandra Singh, Steven D. Douglas, Pascal Dournaud, Satoru Eguchi, Emanuel Escher, Edward J. Filardo, Tung M. Fong, Marta Fumagalli, Raul R. Gainetdinov, Marc de Gasparo, Craig Gerard, Marvin C. Gershengorn, Fernand Gobeil, Theodore L. Goodfriend, Cyril Goudet, Karen J. Gregory, Andrew L. Gundlach, Jörg Hamann, Julien Hanson, Richard L. Hauger, Debbie L. Hay, Ákos Heinemann, Morley D. Hollenberg, Nicholas D. Holliday, Mastgugu Horiuchi, Daniël Hoyer, László Hunyady, Ahsan Husain, Adriaan P. IJzerman, Tadashi Inagami, Kenneth A. Jacobson, Robert T. Jensen, Ralf Jockers, Deepa Jonnalagadda, Sadashiva S. Karnik, Klemens Kaupmann, Jacqueline Kemp, Charles Kennedy, Yasuyuki Kihara, Takio Kitazawa, Paweł Kozielewicz, Hans‐Jürgen Kreienkamp, Jyrki P. Kukkonen, Tobias Langenhan, Katie Leach, Davide Lecca, John D. Lee, Susan E. Leeman, Jérôme Leprince, Xaria X. Li, Tom A. Williams, Stephen J. Lolait, Amelie Lupp, Robyn Macrae, Janet J. Maguire, Jean Mazella, Craig A. McArdle and 55 more - British Journal of Pharmacology 2021 cited by 488

  9. The resolution code of acute inflammation: Novel pro-resolving lipid mediators in resolution

    Authors: , , - Seminars in Immunology 2015 cited by 562

  10. Resolvin E1 and protectin D1 activate inflammation-resolution programmes

    Authors: , , , - Nature 2007 cited by 1,181

  11. Protectins and maresins: New pro-resolving families of mediators in acute inflammation and resolution bioactive metabolome

    Authors: , , , , - Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 2014 cited by 496

  12. Human macrophages differentially produce specific resolvin or leukotriene signals that depend on bacterial pathogenicity

    Authors: , , , , , , , - Nature Communications 2017 cited by 295

  13. Structural elucidation and physiologic functions of specialized pro-resolving mediators and their receptors

    Authors: , - Molecular Aspects of Medicine 2017 cited by 329

  14. Maresin 1 activates LGR6 receptor promoting phagocyte immunoresolvent functions

    Authors: , , , , - Journal of Clinical Investigation 2019 cited by 257

  15. Identification of resolvin D2 receptor mediating resolution of infections and organ protection

    Authors: , , , - The Journal of Experimental Medicine 2015 cited by 380

  16. Stereochemical assignment, antiinflammatory properties, and receptor for the omega-3 lipid mediator resolvin E1

    Authors: , , , , , , , , - The Journal of Experimental Medicine 2005 cited by 913

  17. Resolvin E1 Selectively Interacts with Leukotriene B4 Receptor BLT1 and ChemR23 to Regulate Inflammation

    Authors: , , , , , - The Journal of Immunology 2007 cited by 623

  18. Resolvin T-series reduce neutrophil extracellular traps

    Authors: , , , , , - Blood 2021 cited by 97

  19. Resolvin D1 binds human phagocytes with evidence for proresolving receptors

    Authors: , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2010 cited by 718

  20. Identification and signature profiles for pro-resolving and inflammatory lipid mediators in human tissue

    Authors: , , , , - American Journal of Physiology-Cell Physiology 2014 cited by 425

  21. Novel Resolvin D2 Receptor Axis in Infectious Inflammation

    Authors: , , , - The Journal of Immunology 2016 cited by 162

  22. Endogenous lipid- and peptide-derived anti-inflammatory pathways generated with glucocorticoid and aspirin treatment activate the lipoxin A4 receptor

    Authors: , , , , , , , - Nature Medicine 2002 cited by 447

  23. Resolvin D3 and Aspirin-Triggered Resolvin D3 Are Potent Immunoresolvents

    Authors: , , , , , , , - Chemistry & Biology 2013 cited by 249

  24. New pro-resolving n-3 mediators bridge resolution of infectious inflammation to tissue regeneration

    Authors: , , - Molecular Aspects of Medicine 2017 cited by 247